Method of using a cardiovascular graft to reduce thrombosis or platelet adhesion
US11980535B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2021 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | Oct 8, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/432
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.